2007
Cost‐effectiveness of prize‐based contingency management in methadone maintenance treatment programs
Sindelar JL, Olmstead TA, Peirce JM. Cost‐effectiveness of prize‐based contingency management in methadone maintenance treatment programs. Addiction 2007, 102: 1463-1471. PMID: 17645428, PMCID: PMC3072844, DOI: 10.1111/j.1360-0443.2007.01913.x.Peer-Reviewed Original ResearchConceptsPrize-based contingency managementUsual careContingency managementStimulant-negative urine samplesUrine samplesNational Drug Abuse Treatment Clinical Trials NetworkTreatment programMethadone maintenance treatment programIncremental costBaseline urine samplesMulti-site clinical trialMaintenance treatment programMethadone maintenance clinicsClinical Trials NetworkCommunity treatment programsCost-effectiveness studiesCost of treatmentCost-effectiveness analysisPresence of stimulantsCM conditionClinical trialsCommunity clinicsMaintenance clinicsEffectiveness trialTreatment outcomes
2005
The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment
Dodge R, Sindelar J, Sinha R. The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment. Journal Of Substance Use And Addiction Treatment 2005, 28: 189-196. PMID: 15780549, DOI: 10.1016/j.jsat.2004.12.005.Peer-Reviewed Original ResearchMeSH KeywordsAdultAmbulatory CareComorbidityConnecticutCross-Sectional StudiesDepressionFemaleFinancing, GovernmentHumansMaleMiddle AgedMotivationPatient CompliancePatient DischargePublic AssistanceRegression AnalysisSecondary PreventionSocioeconomic FactorsSubstance Abuse DetectionSubstance-Related DisordersTreatment OutcomeConceptsLength of staySubstance abuse treatment outcomesOutpatient substance abuse treatmentSubstance abuse treatmentDepressive symptomsInsurance statusTreatment outcomesAbstinence statusDepression symptomsDrug useDrug abstinenceAbuse treatmentReal-world clinical settingHigher depressive symptom scoresOutpatient substance abuse treatment programsDepressive symptom scoresSubstance abuse treatment programsSymptom scoresTreatment characteristicsPrimary drugDecreased likelihoodReferral sourceClinical settingSymptomsTreatment program